Abstract OT3-02-07: PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)

O Metzger, S Mandrekar,S Loibl, C Mundhenke, S Seiler,P Valagussa,E Lim,D Tripathy,EP Winer,C Huang,L Carey,P Francis,K Miller,MP Goetz,A Prat,S Loi, I Krop, L Gianni, S Delalogue, I Vaz-Luis, T Dockter, J Lanzillotti,E Ciruelos, AM DeMichele

Ongoing Clinical Trials(2019)

引用 10|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要